RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS

RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS

.

Bibliographic Details
Main Authors:	I. A. Burmistrova, A. G. Samoylova, K. A. Glebov, A. E. Panova, T. S. Radina, I. A. Vasilyeva
Format:	Article
Language:	Russian
Published:	NEW TERRA Publishing House 2019-01-01
Series:	Tuberkulez i Bolezni Lëgkih
Online Access:	https://www.tibl-journal.com/jour/article/view/1206

Similar Items

MUTATIONS OF MYCOBACTERIUM TUBERCULOSIS CAUSING RESISTANCE TO RIFAMPICIN AND ISONIAZID IN THE PATIENTS WITH DIFFERENT HIV STATUS
by: E. I. Veselova, et al.
Published: (2019-02-01)

Drug resistance pattern of <i>M. tuberculosis</i> in those who developed the disease after exposure to MDR/XDR pulmonary tuberculosis
by: K. A. Glebov, et al.
Published: (2020-01-01)

Susceptibility of Rifampicin-Isoniazid Resistant Mycobacterium Tuberculosis Isolates Against Levofloxacin
by: A. H. Kurniawan, et al.
Published: (2016-01-01)

Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis
by: I. A. Burmistrova, et al.
Published: (2019-09-01)

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.
by: Leonela Villegas, et al.
Published: (2016-01-01)

High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
by: Naima Fasih, et al.
Published: (2012-01-01)

Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis
by: Saba Kabir, et al.
Published: (2021-02-01)

Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates
by: M Hamze, et al.
Published: (2015-01-01)

Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01)

Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?
by: Claudia M Denkinger, et al.
Published: (2014-01-01)

Treatment of isoniazid-resistant pulmonary tuberculosis
by: Lim Si, et al.
Published: (2008-01-01)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
by: Byung Woo Jhun, M.D., et al.
Published: (2020-01-01)

Development of liposome formulations of ethambutol, rifampicin, and isoniazid for pulmonary treatment of tuberculosis
by: Wiens, Theresa M.
Published: (2009)

Development of liposome formulations of ethambutol, rifampicin, and isoniazid for pulmonary treatment of tuberculosis
by: Wiens, Theresa M.
Published: (2009)

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients
by: A. K. Hemanth Kumar, et al.
Published: (2018-01-01)

Pre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitro.
by: Indra Bergval, et al.
Published: (2012-01-01)

Evaluation of biochip system in determining isoniazid and rifampicin resistances of mycobacterium tuberculosis in sputum samples.
by: Wei Lu, et al.
Published: (2012-01-01)

Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates
by: Muthuraj Muthaiah, et al.
Published: (2017-08-01)

Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis
by: Soniya Sharma, et al.
Published: (2014-01-01)

Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
by: Zayniddin Sayfutdinov, et al.
Published: (2021-03-01)

Detection of MTB resistance to rifampicin and isoniazid by nitrate reductase assay
by: M. Mohiedden AbdelHaleim, et al.
Published: (2014-04-01)

Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01)

Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains
by: Diana Machado, et al.
Published: (2018-03-01)

Acquired Resistance to Isoniazid During Isoniazid Monotherapy in a Subject with Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact: A Case Report
by: Li TL, et al.
Published: (2021-04-01)

Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
by: Edgar Kigozi, et al.
Published: (2018-01-01)

Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
by: Gadissa Bedada Hundie, et al.
Published: (2016-01-01)

Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.
by: Sabira Tahseen, et al.
Published: (2020-01-01)

The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance.
by: Armand Van Deun, et al.
Published: (2020-01-01)

Drug resistance of <i>M. tuberculosis</i> (historical aspects, current level of knowledge)
by: I. A. Burmistrova, et al.
Published: (2020-02-01)

Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis
by: Melese Abate Reta, et al.
Published: (2021-09-01)

Therapeutic drug monitoring of rifampicin, isoniazid, and pyrazinamide in newly-diagnosed pulmonary tuberculosis outpatients in Denpasar area
by: Ida Ayu Alit Widhiartini, et al.
Published: (2019-04-01)

Resazurin microtiter assay for isoniazid, rifampicin, ethambutol and streptomycin resistance detection in Mycobacterium tuberculosis: Updated metaanalysis
by: Ahmet Yilmaz Coban, et al.
Published: (2014-01-01)

Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
by: El mashad Noha, et al.
Published: (2009-01-01)

Correction: Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
by: Gadissa Bedada Hundie, et al.
Published: (2017-01-01)

Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
by: El mashad Noha, et al.
Published: (2009-02-01)

Sputum culture and drug sensitivity testing outcome among X-pert Mycobacterium tuberculosis/rifampicin-positive, rifampicin-resistant sputum: A retrospective study — Not all rifampicin resistance is multi-drug resistant
by: Lebogang Kenaope, et al.
Published: (2020-06-01)

Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
by: James B. Whitney, et al.
Published: (2002-12-01)

Gastric-resistant isoniazid pellets reduced degradation of rifampicin in acidic medium
by: Fátima Duarte Freire, et al.
Published: (2014-12-01)

Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB® Kit for the diagnosis of tuberculosis.
by: Francesco Bisognin, et al.
Published: (2020-01-01)

IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. G. Samoylova, et al.
Published: (2016-09-01)